Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12610000499088Phase 4Not yet recruiting
Phase 4, open-label, single-arm trial of dexmedetomidine, sponsored by Michael Keane. Primary endpoints: Acceptability to surgeons, Patient satisfaction and 1 more. Planned start Jun 2010; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12610000499088.